Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

516698

registered interest
date	28/04/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Psoriasis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the cost to the public purse is of NHS psoriasis patients continuing their current treatment who do not reach the NICE goal of 75 per cent skin clearance from treatment start.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	36027
answer	answer is ministerial correction date of answer 04/05/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has approved a number of different treatments for psoriasis as part of its technology appraisal (TA) programme, the most recent of these being Secukinumab, which was recommended as a possible treatment for people with plaque psoriasis in July 2015. The National Health Service is legally obliged to fund medicines and treatments recommended by NICE's TA programme, meaning people can access these treatments wherever they live in the country.</p><p>Information regarding the cost to the NHS of the continued treatment of psoriasis patients who do not achieve 75% skin clearance is not collected. The NICE best practice guideline <em>Psoriasis: assessment and management, </em>published in October 2012, covers approaches to diagnosis and treatment and specialist referral. The majority of TA recommended psoriasis treatments are featured in the guideline, and their success in treating psoriasis is measured using Psoriasis Area Severity Index (PASI) and Dermatology Life Quality Index. PASI is a quantitative rating score for measuring the severity of psoriatic lesions based on area coverage and plaque appearance. In most cases, NICE defines an adequate response to treatment as one that includes a 75% reduction in a PASI score. The NICE guidance can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/cg153/resources/psoriasis-assessment-and-management-35109629621701" target="_blank">www.nice.org.uk/guidance/cg153/resources/psoriasis-assessment-and-management-35109629621701</a></p><p>For patients who do not responded adequately to either topical treatment or biological therapies, such as those recommended by the NICE TA programme, the guidance recommends referral to a specialised service. NHS England commissions specialised dermatology services nationally and has set out what providers must have in place in order to deliver specialised dermatology care, as well as defining referral criteria. For psoriasis patients, referrals are appropriate where their condition is severe and they have not responded to NICE approved biological therapies. More information on specialised dermatology services can be found at the following link:</p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 36026 question first answered 04/05/2016 11:42:07 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

516700

registered interest
date	28/04/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Psoriasis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that patients with psoriasis are able to access the most effective NICE-approved treatment for their condition regardless of where they live in the country.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	36026
answer	answer is ministerial correction date of answer 04/05/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has approved a number of different treatments for psoriasis as part of its technology appraisal (TA) programme, the most recent of these being Secukinumab, which was recommended as a possible treatment for people with plaque psoriasis in July 2015. The National Health Service is legally obliged to fund medicines and treatments recommended by NICE's TA programme, meaning people can access these treatments wherever they live in the country.</p><p>Information regarding the cost to the NHS of the continued treatment of psoriasis patients who do not achieve 75% skin clearance is not collected. The NICE best practice guideline <em>Psoriasis: assessment and management, </em>published in October 2012, covers approaches to diagnosis and treatment and specialist referral. The majority of TA recommended psoriasis treatments are featured in the guideline, and their success in treating psoriasis is measured using Psoriasis Area Severity Index (PASI) and Dermatology Life Quality Index. PASI is a quantitative rating score for measuring the severity of psoriatic lesions based on area coverage and plaque appearance. In most cases, NICE defines an adequate response to treatment as one that includes a 75% reduction in a PASI score. The NICE guidance can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/cg153/resources/psoriasis-assessment-and-management-35109629621701" target="_blank">www.nice.org.uk/guidance/cg153/resources/psoriasis-assessment-and-management-35109629621701</a></p><p>For patients who do not responded adequately to either topical treatment or biological therapies, such as those recommended by the NICE TA programme, the guidance recommends referral to a specialised service. NHS England commissions specialised dermatology services nationally and has set out what providers must have in place in order to deliver specialised dermatology care, as well as defining referral criteria. For psoriasis patients, referrals are appropriate where their condition is severe and they have not responded to NICE approved biological therapies. More information on specialised dermatology services can be found at the following link:</p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 36027 question first answered 04/05/2016 11:42:07 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

486954

registered interest
date	24/03/2016
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Passports: Photographs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, if she will arrange a meeting between the Photo Marketing Association and the Passport Office to discuss ensuring that future digitally-supplied ID photographs meet International Civil Aviation Organisation compliance standards and are supplied by photographic professionals.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	32622
answer	answer is ministerial correction date of answer 22/04/2016 answer text <p>Photographic requirements for the British passport are set out in www.gov.uk and are fully compliant with standards set by the International Civil Aviation Organisation. HMPO does not currently require passport photographs to be supplied by photographic professionals and there are no plans to change this.</p><p>The PMA is a member of the Open Identity Exchange (OIX) with whom HM Passport Office has been actively discussing our digital services to ensure open and transparent engagement with all photographic providers.</p> answering member constituency Hemel Hempstead answering member printed Mike Penning question first answered 22/04/2016 10:24:36 answering member 1528 label Biography information for Sir Mike Penning
tabling member	103 label Biography information for Sir Paul Beresford

487134

registered interest
date	24/03/2016
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Proof of Identity: Photographs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, what discussions he has had with officials of the Home Office and the police on proposals to allow members of the public to take their own ID photos for official documents on their own digital devices and the potential effect of this on ID fraud and quality of images.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	32646
answer	answer is ministerial correction date of answer 11/04/2016 answer text <p>Government departments are fully committed to ensuring that the risks of identity fraud are minimised in transactions requiring photographs to be submitted. Currently applicants send paper photographs through the postal service. Technology now enables digital photographs to be submitted in online applications. In whichever channel is used the applicant must attest that the picture is a true likeness and departments put processes in place to assess the end-to-end risks of identity fraud. New technology has the potential to reduce fraud in this process, and we are investigating how technology can be used in a way that is both safe and cost effective.</p><p> </p> answering member constituency West Suffolk answering member printed Matthew Hancock question first answered 11/04/2016 09:52:46 answering member 4070 label Biography information for Matt Hancock
tabling member	103 label Biography information for Sir Paul Beresford

487135

registered interest
date	24/03/2016
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Driving Licences: Photographs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what meetings the Driver and Vehicle Licensing Agency (DVLA) has had with the professional photographic sector since June 2015; and if he will request that the DVLA meets representatives of the Photo Marketing Association to discuss the future provision of digital ID photographs.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	32647
answer	answer is ministerial correction date of answer 11/04/2016 answer text <p>The Driver and Vehicle Licensing Agency (DVLA) has met with representatives of the professional photographic sector on six occasions since June 2015. My noble Friend the Parliamentary Under-Secretary of State, the minister with responsibility for the DVLA and DVLA officials are due to meet with the Photo Marketing Association on 27 April.</p> answering member constituency Harrogate and Knaresborough answering member printed Andrew Jones question first answered 11/04/2016 13:00:21 answering member 3996 label Biography information for Andrew Jones
tabling member	103 label Biography information for Sir Paul Beresford

348293

registered interest
date	03/06/2015
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Dangerous Dogs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, how many deaths and injuries have been caused by prohibited animals which are (a) not on and (b) on the Index of Exempted Dogs in each of the last five years.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	1007
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>There are no records held on the numbers of deaths or injuries caused by dogs held on the Index of Exempted Dogs. However, annual statistics for the last full five years, published by the Health &amp; Social Care Information Centre, on Counts of Finished Admission Episodes for dog bites and strikes is contained in the attached table (the figures should be read in conjunction with the footnotes to the table).</p><p> </p><p> </p><p> </p><p>In addition, the number of people killed by dogs each year for the last full five years is as follows:</p><p> </p><table><tbody><tr><td>2010</td><td>2</td></tr><tr><td>2011</td><td>0</td></tr><tr><td>2012</td><td>3</td></tr><tr><td>2013</td><td>4</td></tr><tr><td>2014</td><td>5</td></tr></tbody></table><p><br></p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong>Counts of Finished Admission Episodes (FAEs)<sup>1</sup> for dog bites and strikes<sup>2</sup>, 2009-10 to 2013-14<sup>3</sup></strong></p><p> </p><p> </p><p> </p><p>Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector</p><p> </p><table><tbody><tr><td><p><strong>Year</strong></p></td><td><p><strong>FAEs</strong></p></td></tr><tr><td><p>2009-10</p></td><td><p>5,837</p></td></tr><tr><td><p>2010-11</p></td><td><p>6,005</p></td></tr><tr><td><p>2011-12</p></td><td><p>6,580</p></td></tr><tr><td><p>2012-13</p></td><td><p>6,317</p></td></tr><tr><td><p>2013-14</p></td><td><p>6,836</p></td></tr></tbody></table><p> </p><p>Source: Hospital Episode Statistics (HES), Health and Social Care Information Centre</p><p> </p><p> </p><p> </p><p>1. Finished admission episodes A finished admission episode (FAE) is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.</p><p> </p><p>2. External cause codes</p><p> </p><p>A supplementary code that indicates the nature of any external cause of injury, poisoning or other adverse effects. Only the first external cause code which is coded within the episode is counted in HES.</p><p> </p><p> </p><p> </p><p>ICD-10 code used: W54 - Bitten or struck by dog</p><p> </p><p> </p><p> </p><p>3. Assessing growth through time (Admitted patient care)</p><p> </p><p>HES figures are available from 1989-90 onwards. Changes to the figures over time need to be interpreted in the context of improvements in data quality and coverage (particularly in earlier years), improvements in coverage of independent sector activity (particularly from 2006-07) and changes in NHS practice. For example, apparent reductions in activity may be due to a number of procedures which may now be undertaken in outpatient settings and so no longer include in admitted patient HES data. Conversely, apparent increases in activity may be due to improved recording of diagnosis or procedure information.</p><p>Note that Hospital Episode Statistics (HES) include activity ending in the year in question and run from April to March, e.g. 2012-13 includes activity ending between 1st April 2012 and 31st March 2013.</p> answering member constituency Camborne and Redruth answering member printed George Eustice question first answered 08/06/2015 16:22:15 answering member 3934 label Biography information for George Eustice
tabling member	103 label Biography information for Sir Paul Beresford

348047

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the treatment of hidradenitis suppurativa cost the NHS in England in (a) 2012, (b) 2013 and (c) 2014.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	745
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurative (HS) affects around 90,000 people in England and can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin.</p><p> </p><p> </p><p> </p><p>For those patients with the most serious forms of HS who cannot be managed through routine access treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with a involvement of a range of health and care professionals, subject to that patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p><p> </p><p> </p><p>The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 746 question first answered 08/06/2015 10:56:15 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

348048

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to support patients with hidradenitis suppurativa.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	746
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurative (HS) affects around 90,000 people in England and can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin.</p><p> </p><p> </p><p> </p><p>For those patients with the most serious forms of HS who cannot be managed through routine access treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with a involvement of a range of health and care professionals, subject to that patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p><p> </p><p> </p><p>The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 745 question first answered 08/06/2015 10:56:15 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

348049

registered interest
date	02/06/2015
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Social Security Benefits: Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, what training is provided to people who carry out assessments for employment and support allowance or personal independence payment on sufferers of hidradenitis suppurativa.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	747
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p /> <p>All healthcare professionals who carry out either Work Capability Assessments or Personal Independence Payment assessments undergo broad and thorough training in disability analysis, as well as training in specific conditions, including progressive conditions. Centre for Health and Disability Assessments, Atos Healthcare and Capita are required to conform to a rigorous set of quality and recruitment standards which are closely monitored by the Department for Work and Pensions.</p> answering member constituency Witham answering member printed Priti Patel question first answered 08/06/2015 09:58:24 answering member 4066 label Biography information for Priti Patel
tabling member	103 label Biography information for Sir Paul Beresford